NeuroMetrix Reports Q1 2024 Business Highlights
May 15, 2024 16:00 ET
|
NeuroMetrix, Inc.
NeuroMetrix, Inc. today reported financial and business highlights for the quarter ended March 31, 2024.
NeuroMetrix announces that over 2000 patients with fibromyalgia have been prescribed Quell® Fibromyalgia
March 13, 2024 09:00 ET
|
NeuroMetrix, Inc.
NeuroMetrix today announced that over 2000 fibromyalgia patients have been prescribed Quell Fibromyalgia since its strategic commercial launch in Dec 2022.
NeuroMetrix Reports Q4 and Full Year 2023 Business Highlights
February 22, 2024 07:00 ET
|
NeuroMetrix, Inc.
NeuroMetrix, Inc. today reported financial and business highlights for the quarter and full year ended December 31, 2023.
NeuroMetrix to Present at the Emerging Growth Conference on November 1, 2023
October 30, 2023 09:00 ET
|
NeuroMetrix, Inc.
NeuroMetrix, Inc. announced today that it will present at the Emerging Growth Conference on Wednesday November 1, 2023 at 3:40PM EDT.
NeuroMetrix Reports Q3 2023 Business Highlights
October 26, 2023 07:00 ET
|
NeuroMetrix, Inc.
NeuroMetrix, Inc. (Nasdaq: NURO) today reported business and financial highlights for the quarter and nine month period ended September 30, 2023.
NeuroMetrix, Inc. Announces Date for Third Quarter 2023 Business and Financial Highlights Conference Call
October 23, 2023 11:13 ET
|
NeuroMetrix, Inc.
NeuroMetrix, Inc. announced today that it plans to issue its Q3 2023 business and financial highlights on October 26, 2023 at 8:00 a.m., Eastern Time.
NeuroMetrix and the National Fibromyalgia Association to Collaborate to Improve the Quality of Life for People Living with Fibromyalgia
October 02, 2023 09:00 ET
|
NeuroMetrix, Inc.
NeuroMetrix, Inc. announced that it has been selected as a Proud Sponsor of the National Fibromyalgia Association (NFA).
NeuroMetrix to Present at the Emerging Growth Conference on October 4, 2023
September 28, 2023 12:19 ET
|
NeuroMetrix, Inc.
NeuroMetrix, Inc. announced today that it will present at the Emerging Growth Conference on October 4, 2023 at 3:55pm EDT.
NeuroMetrix Reports Q2 2023 Business Highlights
July 27, 2023 07:00 ET
|
NeuroMetrix, Inc.
WOBURN, Mass., July 27, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported business and financial highlights for the quarter and six months period ended June 30, 2023. The...
NeuroMetrix Announces Sales Force Expansion for Quell Fibromyalgia
July 11, 2023 09:00 ET
|
NeuroMetrix, Inc.
WOBURN, Mass., July 11, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced expansion of its sales force to drive further adoption of Quell® Fibromyalgia, which is the first...